I want to share with you some important information about a bipartisan bill advancing in the U.S. Senate that ACS CAN has been closely monitoring the Prescription Drug User Fee Act (PDUFA). This is a critical bill for cancer patients and their loved ones.
I am pleased to share with you that U.S. Senators Dick Durbin (D-Ill.), Frank Lautenberg (D-N.J.) and Richard Blumenthal (D-Conn.) introduced a bill last week that would eliminate disparities in the federal tax rates for various tobacco products, a proposal that will increase federal revenues and save lives.
I recently returned from one of the best events ACS CAN hosts all year the State Lead Ambassador Summit. With one in every state, State Lead Ambassadors (SLAs) are ACS CAN's top ranking grassroots volunteers. They coordinate all volunteer-led work across their state.
Earlier this month, as part of National Minority Cancer Awareness Week, ACS CAN co-hosted an important briefing on Capitol Hill to discuss the importance of research and prevention in eliminating inequities among minority populations in prevalence rates of and access to health care for chronic diseases.
When you think of a friend or loved one who is battling cancer, you probably imagine their chemotherapy being administered intravenously at a local hospital. However, modern advances in technology and pharmaceuticals have produced chemotherapy drugs that can be taken orally, in pill form. To date, the FDA has approved more than 40 oral anti-cancer medications for the treatment of at least 54 different types of cancer.